Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis B virus (HBV) polymerase is a multi-domain enzyme essential for HBV replication. It functions as a reverse transcriptase, converting viral RNA into DNA within cytoplasmic capsids. The protein consists of Terminal Protein (TP), Spacer, Reverse Transcriptase (RT), and RNase H domains, each playing a crucial role in the replication process. It is a primary target for antiviral drugs, but resistance can develop due to mutations in the RT domain. The polymerase is essential for viral replication and is a major therapeutic target.
Inhibition of reverse transcriptase activity, leading to termination of DNA synthesis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B polymerase protein.